Citius Oncology Inc. (CTOR)
NASDAQ: CTOR
· Real-Time Price · USD
3.46
0.70 (25.36%)
At close: Jun 26, 2025, 3:59 PM
3.59
3.74%
After-hours: Jun 26, 2025, 07:59 PM EDT
25.36% (1D)
| Bid | 3.41 |
| Market Cap | 247.62M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.66M |
| EPS (ttm) | -0.38 |
| PE Ratio (ttm) | -9.11 |
| Forward PE | 53.8 |
| Analyst | Hold |
| Ask | 3.59 |
| Volume | 1,672,129 |
| Avg. Volume (20D) | 2,037,535 |
| Open | 2.82 |
| Previous Close | 2.76 |
| Day's Range | 2.66 - 3.49 |
| 52-Week Range | 0.55 - 49.00 |
| Beta | -0.06 |
About CTOR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTOR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTOR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+4.32%
CTOR stock has given up its prior gain. Citius Onc...
Unlock content with
Pro Subscription
1 week ago
+4.32%
Citius Oncology shares are trading higher after the company said it expects the commercial launch LYMPHIR in the second half of 2025.